Showing 41 - 50 of 82,022
The past several decades have seen the creation of transformative new technologies that are being used to design innovative consumer product ingredients never seen before in nature. Examples include the use of nanotechnology and genetic modification, and, right around the corner, cloning and lab...
Persistent link: https://www.econbiz.de/10014159491
discriminatory usage of genetic data by employers or insurance companies; and rules limiting redisclosure without the consent of the …
Persistent link: https://www.econbiz.de/10014147467
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10013311658
Persistent link: https://www.econbiz.de/10001727843
• Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers The author …
Persistent link: https://www.econbiz.de/10012397585
Persistent link: https://www.econbiz.de/10011844242
The advantages and disadvantages of genetic modification of organisms in agriculture are reviewed. These relate to the environment, human health, socio-economic effects, population growth, and differential consequences for developed and developing countries. An overall evaluation requires that...
Persistent link: https://www.econbiz.de/10010324896
Persistent link: https://www.econbiz.de/10003896741
Persistent link: https://www.econbiz.de/10003905802
Persistent link: https://www.econbiz.de/10003952267